Dr. Silvia Buonvino graduated with honors in “Chemical Sciences and Technologies” from the University of Rome Tor Vergata, where she later earned a PhD in “Biochemistry and Molecular Biology” working in the “Biochemistry and Biomaterials for Tissue Engineering” laboratory (Prof. Sonia Melino).

After her PhD, she was awarded a Research Fellowship as part of the HEAL ITALIA project (MUR-PNRR) for the development of new systems for precision medicine at the Department of Experimental Medicine of the University of Rome Tor Vergata. Her research focuses on studying the effects of slow H2S-releasing agents on 3D cell culture systems based on hybrid protein hydrogels.

Her studies aim at the biochemical and mechano-physical production and optimization of such 3D culture systems in both regenerative medicine, using mesenchymal stem cells, and in the development of in vitro cancer models, specifically using breast cancer cells. Recently, she has directed her research towards producing complex co-culture systems for the development and characterization of new drug screening platforms.

During her PhD program, she spent research periods at the Technion Institute of Technology in Haifa, Israel, where she worked on developing new devices to study cell migration in three-dimensional systems. In teaching, she has served as a tutor and exam committee member and has delivered lectures for the courses “Biochemistry and Laboratory” (Master’s Degree in Chemical Sciences and Technologies) and “Macromolecules and Biochemical Processes” (Master’s Degree in Materials Science and Technologies).

In 2023 she obtained the professional qualification of Chemist. From October 2024, she is Researcher (type A) for the scientific-disciplinary sector BIOS-07/A (BIO/10) Biochemistry, at UniCamillus – Saint Camillus International University of Health and Medical Sciences (in Rome), for the Master’s Degree courses in Medicine and Surgery, Dentistry and Dental Prosthetics, and the Bachelor’s Degree in Nursing.